Infinity Pharma (INFI) Posts Mixed Q2 Results

Infinity Pharma (NASDAQ: INFI) reported Q2 EPS of $1.05, $1.94 better than the analyst estimate of ($0.89). Revenue for the quarter came in at $9.5 million versus the consensus estimate of $13.91 million.

For earnings history and earnings-related data on Infinity Pharma (INFI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Deutsche Bank Upgrades PennyMac Mortgage Investment Trust (PMT) to Buy
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c